Related Experiment Video
Updated: Jan 8, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Bayesian Modeling to Project the National and Regional Burden of Rheumatic Heart Disease in Brazil Till 2050
Pedro Rafael Vieira de Oliveira Salerno1, Antoinette Cotton2,3, Zhou Chen2
1Department of Medicine, NYC Health & Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, Queens, USA.
Background:
Rheumatic heart disease (RHD) remains a significant public health concern in middle- to low-income countries. Despite advancements in healthcare access and public health measures in Brazil, future projections of RHD burden are essential to guide policy-making. Thus, we projected the national and regional burden of RHD in Brazil through 2050.
Methods:
Annual prevalence counts and disability-adjusted life years (DALYs) for RHD from 2000 to 2021 were extracted from the 2021 Global Burden of Disease (GBD) dataset for 10-year age brackets (5-74 years). Age-standardized prevalence (asPR) and DALYs rates (asDALYs) per 100,000 were calculated nationally and regionally. Bayesian age-period-cohort models were used to project trends through 2050, with results reported as medians (25th, 75th percentiles) and estimated annual percentage changes (EAPCs).
Results:
From 2000 to 2021, Brazil's population grew by 27%. Nationally, the asPR declined slightly from 1,503 to 1,495 per 100,000 [EAPC: -0.04% (95% CI: -0.05, -0.03)], with reductions observed in most regions. However, increases were noted in the North [EAPC: 0.14% (95% CI: 0.13, 0.15)] and Northeast [EAPC: 0.02% (95% CI: 0.01, 0.03)]. Males experienced greater reductions [EAPC: -0.16% (95% CI: -0.19, -0.13)] compared to females, who showed a slight increase [EAPC: 0.05% (95% CI: 0.03, 0.07)]. Projections indicate that asPR will decline nationally to 1,418 per 100,000 by 2050 [EAPC: -0.20% (95% CI: -0.20, -0.19)], with the South and Central West regions reducing the most.The asDALY rates declined from 142 to 104 per 100,000 [EAPC: -1.58% (95% CI: -1.69, -1.46)] during 2000-2021, with all regions showing decreases, particularly the Southeast [EAPC: -1.83% (95% CI: -1.98, -1.69)]. Nationally, projections suggest further reductions to 75 per 100,000 by 2050 [EAPC: -1.17% (95% CI: -1.22, -1.11)].
Conclusion:
The burden of RHD in Brazil has decreased nationally and regionally over recent decades. Projections suggest that these trends will continue.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Statistical Methods for Analyzing Epidemiological Data

